Chris received his PhD and MA in business administration from the Haas School of Business at the University of California, Berkeley, and holds a BA in economics ...

28 aug. 2024 · Christopher Boerner, age 53, serves as board chair for Bristol Myers Squibb since April 2024 and chief executive officer since November 2023.

1 nov. 2023 · Chris Boerner begins his new role as our CEO and on April 1, 2024, he'll succeed Giovanni Caforio as Chair of the Board of Directors.

Christopher Boerner is Chief Commercialization Officer of Bristol Myers Squibb, where he leads commercial strategy and execution across all geographies.

Chris Boerner, who was recently named board chair and CEO of Bristol Myers Squibb (BMS). Boerner swore off science after completing a college biology course.

25 apr. 2024 · Christopher Boerner, 53, took over as the chief executive officer of Bristol Myers Squibb last November, and immediately made a big move: a ...

Guitarist, Producer, Mixer, Mastering Engineer · Photo by Chris Boerner on September 25, 2024. May be a black-and ...

Christopher Boerner is currently the president and head of the US commercial business at Bristol-Myers Squibb. He joined BMS in February 2015.

17 nov. 2023 · CEO Chris Boerner and SVP Cathi Ahearn, Worldwide Commercial Portfolio Strategy, discussed the importance of gender equity, advocacy and ...

Chris Boerner is Chief Executive Officer at Bristol-Myers Squibb Co. See Chris Boerner's compensation, career history, education, & memberships.